PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Breast Cancer
Interventions: DRUG: Lynparza
Sponsor: University of Texas Southwestern Medical Center